Modeling and Simulation - PK/PD Archives | Page 12 of 37 | Certara

Blog

Using Pharmacokinetics to Assure Chemical Food Safety

As a veterinarian, I’m responsible for the health and welfare of my animal patients. Sometimes,…

CertaraMay 12, 2017

Publication

Evaluation of Dosing Strategy for Pembrolizumab for Oncology Indications

CertaraMay 1, 2017

Publication

Effect of Disease-related Changes in Plasma Albumin on the Pharmacokinetics of Naproxen in Male and Female Arthritic Rats

CertaraMay 1, 2017

Publication

Isoniazid Clearance is Impaired Among Human Immunodeficiency Virus/Tuberculosis Patients with High Levels of Immune Activation

CertaraApril 1, 2017

Blog

The Model-informed Precision Dosing Revolution Is Coming

Modeling and simulation (M&S) has been widely accepted and adopted by biopharmaceutical companies and global…

CertaraMarch 7, 2017

Publication

CYP2C9 Genotype-dependent Warfarin Pharmacokinetics: Impact of CYP2C9 Genotype on R- and S-Warfarin and Their Oxidative Metabolites

CertaraMarch 1, 2017

Publication

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

CertaraJanuary 10, 2017

Publication

Clarification of Contraceptive Drug Pharmacokinetics in Obesity

CertaraJanuary 1, 2017

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

CertaraDecember 18, 2016

Brochure

Phoenix IVIVC Toolkit

Explore the comprehensive features of the IVIVC Toolkit.

CertaraDecember 14, 2016

© 2025 Certara. All Rights Reserved. | Privacy policy